MONECO Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.37M Buy
6,143
+969
+19% +$990K 0.45% 47
2026
Q1
$4.76M Buy
5,174
+557
+12% +$565K 0.37% 58
2025
Q4
$4.96M Buy
4,617
+432
+10% +$413K 0.39% 51
2025
Q3
$3.19M Buy
4,185
+43
+1% +$32K 0.27% 79
2025
Q2
$3.23M Buy
4,142
+19
+0.5% +$14.8K 0.3% 70
2025
Q1
$3.41M Sell
4,123
-9
-0.2% -$7.49K 0.35% 63
2024
Q4
$3.19M Buy
4,132
+895
+28% +$741K 0.34% 72
2024
Q3
$2.87M Buy
3,237
+109
+3% +$98K 0.36% 77
2024
Q2
$2.83M Sell
3,128
-1
-0% -$800 0.42% 65
2024
Q1
$2.43M Buy
3,129
+98
+3% +$69.7K 0.39% 70
2023
Q4
$1.77M Buy
3,031
+249
+9% +$145K 0.34% 78
2023
Q3
$1.49M Buy
2,782
+49
+2% +$25.2K 0.41% 60
2023
Q2
$1.28M Buy
2,733
+82
+3% +$34.4K 0.35% 67
2023
Q1
$910K Buy
2,651
+472
+22% +$159K 0.27% 97
2022
Q4
$797K Buy
2,179
+16
+0.7% +$5.67K 0.29% 89
2022
Q3
$699K Sell
2,163
-9
-0.4% -$2.85K 0.28% 87
2022
Q2
$704K Buy
2,172
+675
+45% +$203K 0.27% 87
2022
Q1
$429K Buy
1,497
+63
+4% +$16.2K 0.16% 135
2021
Q4
$351K Buy
1,434
+67
+5% +$17K 0.13% 160
2021
Q3
$316K Sell
1,367
-48
-3% -$11.8K 0.12% 178
2021
Q2
$325K Hold
1,415
0.15% 147
2021
Q1
$264K Buy
1,415
+180
+15% +$35.2K 0.13% 160
2020
Q4
$229K Buy
+1,235
New +$184K 0.13% 155

Other funds holding LLY

MONECO Advisors's LLY Position: Q2 2026 in Review

MONECO Advisors increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $990K and bringing the position to 6,143 shares worth $7.37M. The position accounts for 0.45% of the portfolio, ranked #47.

MONECO Advisors first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MONECO Advisors held 6,143 shares of Eli Lilly worth $7.37M as of Q2 2026.
  • MONECO Advisors bought 969 Eli Lilly shares in Q2 2026, an estimated $990K.
  • Eli Lilly made up 0.45% of MONECO Advisors's portfolio in Q2 2026, its #47 holding.
  • MONECO Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.